company-logo

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

Astria Therapeutics Dividend Announcement

Astria Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Astria Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Astria Therapeutics Dividend History

Astria Therapeutics Dividend Yield

Astria Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Astria Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Astria Therapeutics Financial Ratios

P/E ratio-5.65
PEG ratio-3.98
P/B ratio1.65
ROE-30.79%
Payout ratio0.00%
Current ratio22.38
Quick ratio22.38
Cash Ratio5.14

Astria Therapeutics Dividend FAQ

Does Astria Therapeutics stock pay dividends?
Astria Therapeutics does not currently pay dividends to its shareholders.
Has Astria Therapeutics ever paid a dividend?
No, Astria Therapeutics has no a history of paying dividends to its shareholders. Astria Therapeutics is not known for its dividend payments.
Why doesn't Astria Therapeutics pay dividends?
There are several potential reasons why Astria Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Astria Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Astria Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Astria Therapeutics a dividend aristocrat?
Astria Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Astria Therapeutics a dividend king?
Astria Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Astria Therapeutics a dividend stock?
No, Astria Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Astria Therapeutics stocks?
To buy Astria Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Astria Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.